Bioengineers create pathway to personalized medicine

A group led by chemical and biomolecular engineering professor Matthew DeLisa has devised a cell-free method for producing glycosylated proteins, which could have impacts in personalized medicine. 

Workshop trains plant scientists to communicate science

A Speaking Science course at Cornell June 25-30 trained early-career plant scientists to share their passion for science with the public.

Immunology symposium unites Ithaca, New York City scientists

Cornell experts from Ithaca and New York City gathered June 26-27 at the College of Veterinary Medicine for the Immunology in Health and Disease Symposium.

Dairy barn implements poop-to-power system

Cornell’s College of Veterinary Medicine Teaching Dairy Barn has installed a system that separates manure from sand bedding that is healthier for cows and creates muck perfect for making electricity.

Robert H. Wasserman, discoverer of calcium-binding protein, dies at age 92

Robert Wasserman ’49, Ph.D. ’53, professor emeritus at the Cornell University College of Veterinary Medicine, died May 23 at age 92.

Sadie perseveres with prosthetic paw

With care from new owners and treatment from veterinarians at the Cornell University Hospital for Animals, a stray American foxhound gets a prosthetic limb after losing foot in a coyote trap. 

Moth provides hope against invasive swallow-wort

Pale and black swallow-wort are rapidly invading fields and forests across the Northeast, including New York, but a moth from the Ukraine holds promise to keep the weed in check.

Symposium honors bioengineering pioneer Mike Shuler

Scientists from around the world gathered June 22 to honor the career of Professor Michael Shuler, whose work in modeling biological systems continues to revolutionize the field of bioengineering and change the way pharmaceutical drugs are developed.

Lab-grown tumors provide insights on rare prostate cancer

Growing miniature tumors from a patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists.